INCREASE JOINDER NO. 1QuidelOrtho Corp • August 5th, 2022 • In vitro & in vivo diagnostic substances • New York
Company FiledAugust 5th, 2022 Industry JurisdictionINCREASE JOINDER NO. 1, dated as of August 4, 2022 (this “Agreement”), by and among JPMorgan Chase Bank, N.A., as New Revolving Credit Lender (as defined below), a Lender and a L/C Issuer, QuidelOrtho Corporation, a Delaware corporation (the “Borrower”), the Guarantors party hereto, and Bank of America, N.A., as the Administrative Agent (the “Administrative Agent”).